We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

20 hedge funds and large institutions have $230K invested in Sonoma Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

43% more funds holding

Funds holding: 14 → 20 (+6)

5% less capital invested

Capital invested by funds: $242K → $230K (-$11.7K)

1.56% less ownership

Funds ownership: 5.17% → 3.61% (-1.6%)

Holders
20
Holders Change
+6
Holders Change %
+42.86%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$82.1K
2
DS
DRW Securities
Illinois
+$67.2K
3
Citigroup
Citigroup
New York
+$2.58K
4
Rockefeller Capital Management
Rockefeller Capital Management
New York
+$2.54K
5
TRCT
Tower Research Capital (TRC)
New York
+$2.11K

Top Sellers

Rank Fund Capital Flow
1
HBCM
Heron Bay Capital Management
Michigan
-$96.1K
2
UBS Group
UBS Group
Switzerland
-$56.3K
3
Renaissance Technologies
Renaissance Technologies
New York
-$50.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$81K +$82.1K +20,873 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$68.4K – – –
DS
3
DRW Securities
Illinois
$66.2K +$67.2K +17,070 New
TRCT
4
Tower Research Capital (TRC)
New York
$5.96K +$2.11K +536 +54%
Citigroup
5
Citigroup
New York
$2.54K +$2.58K +656 New
Rockefeller Capital Management
6
Rockefeller Capital Management
New York
$2.51K +$2.54K +646 New
GRP
7
Global Retirement Partners
California
$1.7K +$1.72K +438 New
MCM
8
MAI Capital Management
Ohio
$482 +$488 +124 New
JP Morgan Chase
9
JP Morgan Chase
New York
$477 +$12 +3 +3%
BlackRock
10
BlackRock
New York
$438 – – –
UBS Group
11
UBS Group
Switzerland
$419 -$56.3K -14,309 -99%
US Bancorp
12
US Bancorp
Minnesota
$97 – – –
Bank of America
13
Bank of America
North Carolina
$66 – – –
Morgan Stanley
14
Morgan Stanley
New York
$16 – – –
AF
15
Allworth Financial
California
$12 – – –
QWM
16
Quaker Wealth Management
New Jersey
$12 – – –
Fidelity Investments
17
Fidelity Investments
Massachusetts
$7 +$8 +2 New
DB
18
Danske Bank
Denmark
$4 – – –
SS
19
SBI Securities
Japan
$4 +$4 +1 New
HBCM
20
Heron Bay Capital Management
Michigan
– -$96.1K -33,782 Closed
Renaissance Technologies
21
Renaissance Technologies
New York
– -$50.6K -17,800 Closed

SNOA Hedge Fund Activity: Q3 2025 in Review

20 of the 7,629 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q3 2025, worth a combined $230K — down 4.8% from $242K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new SNOA positions and 2 closed out — a net gain of 6 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $82.1K. The largest seller was Heron Bay Capital Management, exiting entirely with an estimated $96.1K sold.

  • 20 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q3 2025, up from 14 in Q2 2025.
  • Funds reported $230K of Sonoma Pharmaceuticals stock for Q3 2025, down 4.8% quarter-over-quarter.
  • 8 funds opened new Sonoma Pharmaceuticals positions in Q3 2025 and 2 closed out, a net change of +6 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q3 2025 was Vanguard Group, an estimated $82.1K added.
  • The largest Sonoma Pharmaceuticals seller in Q3 2025 was Heron Bay Capital Management, an estimated $96.1K sold.

Based on aggregated 13F filings for Q3 2025.